Shire Opens Tokyo Office, Strengthens Japanese Presence
This article was originally published in PharmAsia News
Executive Summary
British specialty drug maker Shire Feb. 23 opened a representative office in Tokyo. The company appointed former Genzyme Japan executive Soh Fujiwara as managing director. Shire's Hunter syndrome drug Elaprase (idursulfase) is marketed currently in Japan through collaboration with Genzyme. With the opening of the Tokyo office, the company aims to introduce specialty drugs to treat inflammatorily bowel disease, hyperphosphatemia and Fabry's disease to Japan. The Tokyo office is Shire's third office in the Asia-Pacific region, after Singapore and Australia. (Click here for more - Japanese language